Sun-Ranbaxy deal: CCI raises concerns about molecules market
Sun Pharma and Ranbaxy had announced a USD 4-billion deal that would create one of the top five largest speciality generics company in the world.
Aug 29, 2014, 13:51 PM ISTSun Pharma-Ranbaxy deal comes under CCI scanner
CCI would take a final view on the deal after receiving details from them and could seek more information if it is not satisfied with the responses.
Aug 08, 2014, 12:34 PM IST